OSTX Research Development from 2010 to 2024

OSTX Stock   3.97  0.06  1.53%   
OS Therapies Research Development yearly trend continues to be fairly stable with very little volatility. Research Development will likely drop to about 3.2 M in 2024. During the period from 2010 to 2024, OS Therapies Research Development regression line of annual values had r-squared of  0.48 and arithmetic mean of  2,385,473. View All Fundamentals
 
Research Development  
First Reported
2010-12-31
Previous Quarter
3.2 M
Current Value
3.2 M
Quarterly Volatility
437.9 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check OS Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OS Therapies' main balance sheet or income statement drivers, such as Interest Expense of 2.9 M, Selling General Administrative of 1 M or Total Revenue of 0.0, as well as many indicators such as . OSTX financial statements analysis is a perfect complement when working with OS Therapies Valuation or Volatility modules.
  
Check out the analysis of OS Therapies Correlation against competitors.

Latest OS Therapies' Research Development Growth Pattern

Below is the plot of the Research Development of OS Therapies Incorporated over the last few years. It is OS Therapies' Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OS Therapies' overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

OSTX Research Development Regression Statistics

Arithmetic Mean2,385,473
Geometric Mean2,353,346
Coefficient Of Variation18.36
Mean Deviation338,070
Median2,174,179
Standard Deviation437,917
Sample Variance191.8B
Range1.1M
R-Value0.69
Mean Square Error108.3B
R-Squared0.48
Significance0
Slope67,531
Total Sum of Squares2.7T

OSTX Research Development History

20243.2 M
20233.2 M
20223.3 M

About OS Therapies Financial Statements

OS Therapies investors use historical fundamental indicators, such as OS Therapies' Research Development, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in OS Therapies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development3.2 M3.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for OSTX Stock Analysis

When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.